Drugs / Gimeracil and Oteracil Potassium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02008422 Background | Aug 2013 → May 2016 | gastric cancer | Tang Xushan | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gimeracil and Oteracil Potassium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02008422 ↗ |
| Route | Oral | “40 mg/m2, po., Bid., d1-14, 21 d as a cycle.” NCT02008422 ↗ |